N-Acetyl Selank Amidate vs N-Acetyl Semax Amidate
Comparison of N-Acetyl Selank Amidate (Very Low evidence) and N-Acetyl Semax Amidate (Very Low evidence).
Last updated: February 12, 2026
N-Acetyl Selank Amidate
N-Acetyl Semax Amidate
Overview
N-Acetyl Selank Amidate and N-Acetyl Semax Amidate are both studied in the peptide research space.
N-Acetyl Selank Amidate: A modified version of Selank with N-terminal acetylation and C-terminal amidation designed to enhance stability and bioavailability.
N-Acetyl Semax Amidate: A chemically modified version of Semax with N-terminal acetylation and C-terminal amidation designed to enhance peptide stability.
Evidence Comparison
| Aspect | N-Acetyl Selank Amidate | N-Acetyl Semax Amidate |
|---|---|---|
| Evidence Level | Very Low | Very Low |
| Human Studies | 0 | 0 |
| Preclinical Studies | 2 | 2 |
| Total Sources | 2 | 2 |
Key Differences
| Aspect | N-Acetyl Selank Amidate | N-Acetyl Semax Amidate |
|---|---|---|
| Category | Cognitive | Cognitive |
| Evidence Strength | Very Low | Very Low |
| Total Sources | 2 | 2 |
| Human Studies | 0 | 0 |
Summary
- N-Acetyl Selank Amidate: Very Low evidence with 2 total sources (0 human)
- N-Acetyl Semax Amidate: Very Low evidence with 2 total sources (0 human)
This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.